Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohit Mathur

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Kidney International Reports|May 16, 2022
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG<sub>2</sub> Monoclonal Antibody, in Healthy VolunteersMohit Mathur, Jonathan Barratt, Yusuke Suzuki, et al.
Journal of Clinical Medicine|November 14, 2023
A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the EvidenceMohit Mathur, Tak Mao Chan, Kook-Hwan Oh, et al.
Journal of Clinical Medicine|December 17, 2024
Comparing Prescribing Behaviors and Clinician Experiences Between Multiplex PCR/Pooled Antibiotic Susceptibility Testing and Standard Urine Culture in Complicated UTI CasesEmery Haley, Natalie Luke, Howard Korman, et al.
Research and Reports in Urology|May 8, 2023
A Diagnostic Test Combining Molecular Testing with Phenotypic Pooled Antibiotic Susceptibility Improved the Clinical Outcomes of Patients with Non-<i>E. coli</i> or Polymicrobial Complicated Urinary Tract InfectionsHoward J Korman, David Baunoch, Natalie Luke, et al.
Infection and Drug Resistance|May 16, 2023
Multiplex Polymerase Chain Reaction/Pooled Antibiotic Susceptibility Testing Was Not Associated with Increased Antibiotic Resistance in Management of Complicated Urinary Tract InfectionsHoward J Korman, Mohit Mathur, Natalie Luke, et al.
Research and Reports in Urology|January 15, 2024
The Prevalence and Association of Different Uropathogens Detected by M-PCR with Infection-Associated Urine Biomarkers in Urinary Tract InfectionsEmery Haley, Natalie Luke, Mohit Mathur, et al.
Clinical Pharmacology in Drug Development|August 11, 2023
Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy ParticipantsXiaoyan Zhang, Yanlin Wang, Jill Yarbrough, et al.
Kidney360|May 25, 2023
Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic ReviewKrzysztof Kiryluk, Daniel E Freedberg, Jai Radhakrishnan, et al.
Pediatric Health, Medicine and Therapeutics|November 27, 2024
Noninferiority of Multiplex Polymerase Chain Reaction Compared to Standard Urine Culture for Urinary Tract Infection Diagnosis in Pediatric Patients at Hackensack Meridian Health Children's Hospital Emergency DepartmentSejal M Bhavsar, Nisha Polavarapu, Emery Haley, et al.
BMC Infectious Diseases|April 7, 2019
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantationG V Ramesh Prasad, Jill Beckley, Mohit Mathur, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Kidney International Reports|May 16, 2022
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG<sub>2</sub> Monoclonal Antibody, in Healthy VolunteersMohit Mathur, Jonathan Barratt, Yusuke Suzuki, et al.
Journal of Clinical Medicine|November 14, 2023
A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the EvidenceMohit Mathur, Tak Mao Chan, Kook-Hwan Oh, et al.
Journal of Clinical Medicine|December 17, 2024
Comparing Prescribing Behaviors and Clinician Experiences Between Multiplex PCR/Pooled Antibiotic Susceptibility Testing and Standard Urine Culture in Complicated UTI CasesEmery Haley, Natalie Luke, Howard Korman, et al.
Research and Reports in Urology|May 8, 2023
A Diagnostic Test Combining Molecular Testing with Phenotypic Pooled Antibiotic Susceptibility Improved the Clinical Outcomes of Patients with Non-<i>E. coli</i> or Polymicrobial Complicated Urinary Tract InfectionsHoward J Korman, David Baunoch, Natalie Luke, et al.
Infection and Drug Resistance|May 16, 2023
Multiplex Polymerase Chain Reaction/Pooled Antibiotic Susceptibility Testing Was Not Associated with Increased Antibiotic Resistance in Management of Complicated Urinary Tract InfectionsHoward J Korman, Mohit Mathur, Natalie Luke, et al.
Research and Reports in Urology|January 15, 2024
The Prevalence and Association of Different Uropathogens Detected by M-PCR with Infection-Associated Urine Biomarkers in Urinary Tract InfectionsEmery Haley, Natalie Luke, Mohit Mathur, et al.
Clinical Pharmacology in Drug Development|August 11, 2023
Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy ParticipantsXiaoyan Zhang, Yanlin Wang, Jill Yarbrough, et al.
Kidney360|May 25, 2023
Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic ReviewKrzysztof Kiryluk, Daniel E Freedberg, Jai Radhakrishnan, et al.
Pediatric Health, Medicine and Therapeutics|November 27, 2024
Noninferiority of Multiplex Polymerase Chain Reaction Compared to Standard Urine Culture for Urinary Tract Infection Diagnosis in Pediatric Patients at Hackensack Meridian Health Children's Hospital Emergency DepartmentSejal M Bhavsar, Nisha Polavarapu, Emery Haley, et al.
BMC Infectious Diseases|April 7, 2019
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantationG V Ramesh Prasad, Jill Beckley, Mohit Mathur, et al.
Pageof 5